...was also on the payroll of pharmaceutical manufacturers, but forgot to mention it. This, of course, calls to mind some of the issues raised by the recent U of Minnesota controversy.
UPDATE: This is also relevant, though as with the author's prior piece in the NYRB, I think she is a bit too willing to treat placebo effects as fully explanatory of improvements. (Thanks to Daniel Groll for the pointer.)
Recent Comments